Navigating the fine line between benefit and risk in chronic atrial fibrillation: Rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY)

dc.contributor.authorCarrington, Melinda
dc.contributor.authorBall, Jocasta
dc.contributor.authorHorowitz, John D.
dc.contributor.authorMarwick, Thomas H.
dc.contributor.authorMahadevan, Gnanadevan
dc.contributor.authorWong, Chiew
dc.contributor.authorAbhayaratna, Walter
dc.contributor.authorHaluska, Brian
dc.contributor.authorThompson, David R
dc.contributor.authorScuffham, Paul A
dc.contributor.authorStewart, Simon
dc.date.accessioned2015-12-07T22:15:11Z
dc.date.issued2011
dc.date.updated2016-02-24T11:31:34Z
dc.description.abstractBackground: Health outcomes associated with atrial fibrillation (AF) continue to be poor and standard management often does not provide clinical stability. The Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY) compares the efficacy of
dc.identifier.issn0167-5273
dc.identifier.urihttp://hdl.handle.net/1885/17789
dc.publisherElsevier
dc.sourceInternational Journal of Cardiology
dc.subjectKeywords: warfarin; anticoagulant therapy; article; cost effectiveness analysis; event free survival; heart atrium fibrillation; high risk patient; home care; hospital patient; hospital readmission; multicenter study (topic); priority journal; prospective study; ra Anti-coagulation; Atrial fibrillation; Disease management
dc.titleNavigating the fine line between benefit and risk in chronic atrial fibrillation: Rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY)
dc.typeJournal article
local.bibliographicCitation.startpage7
local.contributor.affiliationCarrington , Melinda , Baker IDI Heart and Diabetes Institute
local.contributor.affiliationBall, Jocasta , Monash University
local.contributor.affiliationHorowitz, John D. , The Basil Hetzel Research Institute
local.contributor.affiliationMarwick, Thomas H. , Cleveland Clinic
local.contributor.affiliationMahadevan, Gnanadevan , The Basil Hetzel Research Institute
local.contributor.affiliationWong, Chiew , The Western Hospital
local.contributor.affiliationAbhayaratna, Walter, College of Medicine, Biology and Environment, ANU
local.contributor.affiliationHaluska, Brian , University of Queensland
local.contributor.affiliationThompson, David R, Australian Catholic University
local.contributor.affiliationScuffham, Paul A, Griffith University
local.contributor.affiliationStewart, Simon , Baker IDI Heart and Diabetes Institute
local.contributor.authoremailu3379649@anu.edu.au
local.contributor.authoruidAbhayaratna, Walter, u3379649
local.description.embargo2037-12-31
local.description.notesImported from ARIES
local.identifier.absfor110201 - Cardiology (incl. Cardiovascular Diseases)
local.identifier.absseo970111 - Expanding Knowledge in the Medical and Health Sciences
local.identifier.ariespublicationu4971216xPUB2
local.identifier.citationvolumeOnline 12 November 2011
local.identifier.doi10.1016/j.ijcard.2011.10.065
local.identifier.scopusID2-s2.0-84878013476
local.identifier.thomsonID000319510200021
local.identifier.uidSubmittedByu4971216
local.type.statusPublished Version

Downloads

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
01_Carrington _Navigating_the_fine_line_2011.pdf
Size:
773 KB
Format:
Adobe Portable Document Format